The study indicated that the PS-ELP-VHH conjugate/micelle demonstrated tumor-cell-killing efficiency in a light-dependent manner, indicating an efficient binding between the antibody (VHH) and the antigen (EGFR), as well as a sustained release of ROS generated by the light and the PS in the presence of oxygen. Here, EGFR is linked to neoplasm.